drugset
Drugs / Human Rabies Immunoglobulins
last change Jul 2022 re-read 2 minutes ago

Human Rabies Immunoglobulins

Protein / enzyme biologic

Investigated by
Sanofi Pasteur, a Sanofi Company

Trials 1 · a red edge is where a trial was stopped

today NCT04478084 · Ph 3
202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT04478084 Aug 2020 → Mar 2022 — Sanofi Pasteur, a Sanofi Company Completed No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT04594551 Background Oct 2020 → Jun 2021 — Sanofi Pasteur, a Sanofi Company Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Human rabies immunoglobulins ClinicalTrials.gov intervention name — accepted as the source's own label NCT04478084 ↗
1

NCT04594551 ↗
Modality Protein / enzyme biologic “Human rabies immunoglobulins (HRIG)” NCT04478084 ↗
Route Intramuscular “Route of administration: intramuscular” NCT04478084 ↗